Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial

Evidence-Based GI: An ACG Publication and Podcast - A podcast by American College of Gastroenterology - Wednesdays

Philip Schoenfeld, MD, MSEd, MSc (Epi) discusses “Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis,” by Loomba R, Hartman ML, Lawitz EJ, et al. N Engl J Med June 8, 2024.